Toxicology

Ophthalmic Pharmacology and In Vivo Studies

Call us at 408.738.9260

Comparative Biosciences, Inc. (CBI), a premier ocular research CRO, provides a large variety of validated discovery preclinical ophthalmic research studies including efficacy, pharmacology, or in vivo indications. Our ophthalmologic models include macular degeneration, retinopathies, dry eye, glaucoma, and inflammation. CBI scientists are available to discuss these models in more detail. CBI is also willing to work with our sponsors to develop unique or customized models.

Validated efficacy ophthalmic studies available at CBI include:

  • Choroidal neovascularization in mice and rats (laser-induced)
  • Oxygen-induced retinopathy in mice and rats
  • VEGF-induced choroidal neovascularization in rabbits
  • Streptozotocin-induced retinopathy
  • Senescent knockout mouse model of macular degeneration
  • Melanin-antigen associated uveitis in rats
  • Laser-induced episcleral cautery for glaucoma in rats
  • Chymotrypsin-induced glaucoma in rabbits
  • Concanavalin A-induced dry eye in rabbits
  • Botulinum-induced dry eye in mice
  • Scopolamine-induced dry eye in mice
  • Heptanol-induced corneal erosion in rabbits
  • MNU-induced retinitis pigmentosa
  • Corneal pocket neovascularization
  • LPS-induced inflammation
  • Corneal Infection

Angiogenesis Models

  • angiogenesis laser modelLaser-induced retinal neovascularization (macular degeneration) in mice, rats, and rabbits
  • Retinopathy of prematurity model in infant mice and rats
  • Corneal pockets for neovascularization in rats and rabbits

    Read more on angiogenesis models

Models of Inflammation

Ocular inflammation is a significant unmet medical need and there are a variety of acute immune-mediated models of inflammation that may be used to assess drug activity.

Acute Inflammation

  • LPS-induced inflammation

Immune Mediated

Ovalbumin-induced inflammation

For further information, contact CBI

Corneal Wound Healing Models

Models of Dry Eye

Dry eye, whether immune-mediated or age related, is a significant unmet medical need. There are several standard models for assessment of dry eye therapy available at CBI.

Rabbit Conconavalin A GraphRabbit Conconavalin A-induced dry eye

In this standard model of immune-mediated dry eye, the lacrimal gland is injected with ConA. A self-limiting dry eye develops over about 2 weeks. A typical study design includes:

  • Groups with at least 6 rabbits group recommended
  • Con A injections on Day 0 and Day 3
  • Test article administration either intraocularly or systemically
  • Daily assessments of photography, Schirmer tear test, tear break-up test, pachymetry, and slit lamp assessment
  • Histopathology on eye and adenexal structures

Mouse Scopolomine Thread TestMouse botulinum-induced dry eye

For more information, contact CBI

Mouse scopolomine-induced dry eye

For further information, contact CBI

 

Models of Metabolic Retinopathy

Both the db/db mouse and streptozotin-treated rats develop a diabetic type retinopathy over time. For further information, contact CBI

Retinopathy of prematurityModels of Ocular Infection

For more information on ocular infection, contact CBI.

Models of Glaucoma

Read more about glaucoma